NETANYA, Israel (November 18, 2020)—Eitan Group announced that, as of Nov.16, 2020, it has rebranded, consolidating its product lines under the new Eitan Medical brand. Eitan Medical is a global provider of advanced infusion therapy solutions across the care continuum.
Eitan Medical’s product lines include the Sapphire infusion family, used across the care continuum; Sorrel’s wearable drug delivery platform, the patient-centric on-body injector for delivery of biologic treatments; and Avoset, designed specifically for homecare with dedicated connected infusion systems.
“Rebranding as Eitan Medical marks a major milestone and a unique opportunity for our new name to become synonymous with our advanced, connected infusion therapy solutions,” said Igal Shany, CEO of Eitan Medical. “Our new brand represents our evolving position—committed to delivering infusion solutions that go beyond, providing maximum flexibility for patients and reliability for clinicians across the care continuum, from the hospital to the home.”
Eitan Medical maintains local offices in the United States, France and the UK, whereby existing customers of the Sapphire product line can receive direct support and supply of infusion pumps and accessories. In addition, Eitan Medical continues to expand and successfully partner with leading pharmaceutical companies for its Sorrel wearable drug delivery platform.
Visit eitanmedical.com for more information.
